NCT07032103Recruiting
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
A Prospective Study for Patients With Lymphoma at the Samsung Medical Center
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 13 Jun 2025
- Start date
- 1 Jun 2022
- Primary completion date
- 30 Dec 2028
- Lead sponsor
- Samsung Medical Center
- Diseases
- Childhood cancers
- NCT number
- NCT07032103
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Jun 2022 to the primary completion date, 30 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients do not require systemic chemotherapy with curative intent
Other illness
- Myeloid malignancy
Other
- Multiple myeloma
Who the study is looking for
- Pathologically diagnosed Hodgkin and non-Hodgkin lymphomas
- 20 years
- Patients requiring systemic chemotherapy with curative intent
- Written informed consent
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.